The 2026 AI-Biopharma Power Players: Industrializing the Drug Lifecycle
The artificial intelligence landscape in biopharma during 2025 and 2026 is defined by a rapid transition from exploratory pilot programs to massive, industrialized integrations across the drug development lifecycle. The…